Robeco Institutional Asset Management B.V. Biogen Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $51.9 Billion
- Q4 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Biogen Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 408,276 shares of BIIB stock, worth $58.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
408,276
Previous 274,708
48.62%
Holding current value
$58.3 Million
Previous $53.2 Million
17.25%
% of portfolio
0.12%
Previous 0.11%
Shares
49 transactions
Others Institutions Holding BIIB
# of Institutions
1,010Shares Held
129MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.38 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.33 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.08 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$750 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...